Patient Testimonial: Since I’ve seen Dr. Hanna he has stopped the pain in my neck . He stopped the pain after all this time and no one had ever stopped the pain prior to this. I really appreciate Dr. Hanna’s...
Patient Testimonial: Such a gentleman! I have been very happy with the care I have received at Florida Spine. Dr. Hanna and his staff are wonderful and caring people. The staff at C-Med is also outstanding. As a patient with...
Gizmondo article on Ketamine treatments If you are feeling depressed or anxious and have tried traditional treatments that do not seem to work, Ketamine treatments may be able to help. Dr. Ashraf Hanna is the world’s top Ketamine doctor with...
October 18, 2022 https://nymag.com/ One Saturday afternoon in the fall of 2016, Dr. Sally Smith received a call from the pediatric emergency room at Johns Hopkins All Children’s Hospital in St. Petersburg, Florida. Smith was the medical director of the...
CTInsider article:Jayesh Kamath said the use of ketamine therapies for treatment of depression could be “groundbreaking.” “We’ve been stuck with antidepressants for decades,” he said. Kamath is a professor of psychiatry at the University of Connecticut Health Center. He said...
Article from Psychiatry Advisor: Ketamine was originally approved by the US Food and Drug Administration (FDA) as an anesthetic, but is increasingly being used to treat mood disorders, such as treatment-resistant depression, anxiety disorders, and post-traumatic stress disorder (PTSD).1,2...
MONDAY, Feb. 7, 2022 (HealthDay News) — A new clinical trial strengthens the case that ketamine — once famous as a club drug — can rapidly ease suicidal thoughts. Researchers found that among 156 adults hospitalized for severe suicidal thoughts,...
Researchers at Cincinnati Children’s Hospital Medical Center have concluded that intranasal ketamine is as effective as intranasal fentanyl for the relief of pain from acute extremity injury in children. The findings from a recently completed randomized trial are important in...
The results of a new clinical trial with ketamine were published in Nature’s Molecular Psychiatry journal. Researchers conducted a double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). 99 subjects, 18-70 years old with TRD…
Patient Testimonial
Patient Testimonial
Patient Testimonial
Gizmondo Article: Ketamine treatments
New York Magazine Article: What Happened To Maya? Dr. Ashraf Hanna Treats CRPS Patient
New Article: Ketamine therapy could be ‘groundbreaking’ in treating depression, CT researcher says
Ketamine: A Promising Novel Therapy for Anxiety and PTSD
New article: Ketamine may prevent suicidal ideation
Results of Randomized Trial Confirm Ketamine as Viable Non-opioid Alternative
Double-Blind Clinical Trial Shows that Dose Matters with Ketamine in Depressed Patients
The results of a new clinical trial with ketamine were published in Nature’s Molecular Psychiatry journal. Researchers conducted a double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). 99 subjects, 18-70 years old with TRD…